knowledge -WSS

knowledge

author：Wikipedia 2025-09-30 12:51:51 Page View：5936

close-up of psoriasis on a hand. -- biotech coverage from STAT — A close-up of psoriasis on a hand. Adobe

San Francisco startup Alumis Inc. has raised $259 million in a bid to best big pharma’s work in plaque psoriasis.

Alumis announced its Series C round Wednesday and plans to move its lead drug into Phase 3 trials. Venture firm Foresite Capital, which incubated Alumis, co-led the financing with Samsara BioCapital and venBio Partners.

Alumis’ lead drug, ESK-001, is an oral medicine designed to help patients with the most common type of psoriasis by inhibiting a signaling protein called TYK2. Research has shown that the TYK2 protein plays a role in diseases where the immune system overreacts, which has made it a popular drug target in recent years.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Eli Lilly reports tirzepatide MASH success during Q4 earnings
Next article： Bright Health sells Medicare Advantage business to Molina

leisure time

Malaria cases in Florida and Texas: Here’s what you need to know

MosquitoscaughtfortestingawaitshipmenttoalabinMcAllen,Texas,inApril2016tobetestedformosquito-bornedi

AI can decode, harness the power of the humane immune system

AdobeIftheCovid-19pandemichasshownusonething,itishowlittlewereallyknowabouthowthehumanimmunesystemwo

Jerome Adams on the need for new antivirals for Covid

PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

STAT Boddities: What happens to the brain when we get scared?

Whydowegasp,jumpandgopalewhenwe'refrightened?Itallcomesdowntoatiny,almond-shapedstructureinthebraint

knowledge

focus

leisure time

STAT Boddities: What happens to the brain when we get scared?